Hemostasis and Tissue Sealing Agents Market
Hemostasis and Tissue Sealing Agents Market Size, Share & Trends Analysis Report by Product (Topical Hemostat, Adhesive and Tissue Sealant), by Material (Collagen-based Topical Hemostats, Gelatin based Topical Hemostats, ORC-based Topical Hemostats and Polysaccharide based Topical Hemostats), by Application (General Surgery, Minimally Invasive Surgery, Trauma and Other Applications), by End-Use (Hospitals and Ambulatory Surgical Centers), Forecast Period (2023-2030)
Hemostasis and tissue sealing agents market is anticipated to grow at a CAGR of 9.3% during the forecast period (2023-2030). Pivotal factors attributed to market growth including the growing geriatric population, coupled with the high prevalence of chronic conditions, the volume of surgical procedures is expected to increase. This is further projected to drive demand for wound healing and closure management. According to the National Association of Chronic Disease Directors, about 40% of American adults have multiple chronic conditions, and evidence is growing that one chronic illness has a negative impact on the risk of developing others, particularly as people age. Diabetes as well as neurological, urological, and cardiac diseases are also leading causes of an increase in the volume of surgical procedures.
Segmental Outlook
The global hemostasis and tissue sealing agents market is segmented on the product, material, application, and end-user. Based on the product, the market is sub-segmented into topical hemostat, adhesive and tissue sealant. Based on the material, the market is sub-segmented into collagen-based topical hemostats, gelatin based topical hemostats, ORC-based topical hemostats and polysaccharide based topical hemostats. Based on the application, the market is sub-segmented into general surgery, minimally invasive surgery, trauma, and other applications. Other application includes hemophilia. Further, based on end-user, the market is sub-segmented into hospitals and ambulatory surgical centers. Among the end-user, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the increasing number of emergency hospital visits, offering reimbursement policies and facilities through insurance companies, providing prominent opportunities for the growth of this segment.
The Minimally Invasive Surgeries Sub-Segment is Anticipated to Hold a Considerable Share of the Global Hemostasis and Tissue Sealing Agents Market
Among the application, the minimally invasive surgeries sub-segment is projected to hold a considerable share of the global hemostasis and tissue sealing agents market. Minimally invasive surgeries in urology are particularly making use of hemostatic agents, which is driving market growth. Cardiovascular disorders and general surgery have the most need for hemostatic and tissue sealing agents. The high use of these products in cardiovascular diseases is attributed to better clinical results as compared to other wound closure techniques. According to the WHO, CVDs are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2019. Of these deaths, 85% were due to heart attack and stroke. Hemostats and sealants used in combination minimise treatment times, minimising scarring and accelerating recovery. Manufacturing of hemostat and tissue sealing agents falls under regulations of medical device manufacturing Class II and Class III.
Regional Outlook
The global hemostasis and tissue sealing agents market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the increasing number of surgical procedures as well as the rising number of road accidents, driving the hemostasis and tissue sealing agents market in the North America.
Global Hemostasis and Tissue Sealing Agents Market Growth, by Region 2023-2030
The Europe Region is Expected to Grow at a Significant CAGR in the Global Hemostasis And Tissue Sealing Agents Market
Among all regions, the Europe regions is expected to grow at the fastest CAGR over the forecast period. The growth of the market is attributed to the rising geriatric population, which ultimately leads to a higher number of surgeries, increasing medical tourism, increasing awareness about the use of hemostatic agents, adhesives, and tissue sealants. According to research study published in June 2021 by the German Heart Surgery Report, a total of 92,809 operations were classified as heart surgery procedures in a conventional manner. In 2020, the number of isolated heart transplantations increased to 340, a rise of 2.1% compared with the previous year. According to the British Heart Foundation's February 2021 report, in 2020, around 371,000 heart procedures and operations were performed in England, a 22% drop from 2019 when more than 473,000 were carried out. Hence, the high number of heart surgeries and operations being performed every year may bolster the demand for hemostat agents that control bleeding. Additionally, the launch of advanced and innovative products, such as FLOSEAL, TISEEL, and HEMOPATCH, is expected to propel the demand from European countries. In May 2023, Olympus Europa SE & Co. KG launched the three Endoclot products, two hemostatic agents and a submucosal injection agent, in the Europe, Middle East and Africa region. This new portfolio was developed by Santa Clara, Calif.-based Endoclot Plus Inc., which expanded its distribution with Olympus from the US to EMEA in December 2022. The addition of this solutions to the portfolio allowed Olympus to contribute to safe treatment in gastrointestinal procedures. Which aimed to improve patient outcomes and hereby elevate the standard of care.
Market Players Outlook
The major companies serving the hemostasis and tissue sealing agents market include Baxter International, Inc., Becton, Dickinson & Co., Johnson & Johnson Medical NV, Medtronic Plc., Pfizer, Inc. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2021, Baxter Healthcare Corporation subsidiary of Baxter International Inc., acquired the certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc, for up to $60.8 million, including $25 million paid upfront.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global hemostasis and tissue sealing agents market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Baxter International, Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Becton, Dickinson & Co.,
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Johnson & Johnson Medical NV
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Medtronic Plc.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Pfizer, Inc.
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
4. Market Segmentation
4.1. Global Hemostasis and Tissue Sealing Agents Market by Product
4.1.1. Topical Hemostat
4.1.2. Adhesive and Tissue Sealant
4.2. Global Hemostasis and Tissue Sealing Agents Market by Material
4.2.1. Collagen-based Topical Hemostats
4.2.2. Gelatin based Topical Hemostats
4.2.3. ORC-based Topical Hemostats
4.2.4. Polysaccharide based Topical Hemostats
4.3. Global Hemostasis and Tissue Sealing Agents Market by Application
4.3.1. General Surgery
4.3.2. Minimally Invasive Surgery
4.3.3. Trauma
4.3.4. Other Applications (Hemophilia)
4.4. Global Hemostasis and Tissue Sealing Agents Market by End-User
4.4.1. Hospitals
4.4.2. Ambulatory Surgical Centers
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Advance Medical Solution Group Plc
6.2. Artivion, Inc.,
6.3. B Braun Holding GmbH & Co. KG
6.4. Biomet Inc
6.5. BioSpace, Inc.
6.6. Cohera Medical Inc.,
6.7. Covidien Plc
6.8. Cryolife Inc.,
6.9. Ethicon LLC
6.10. Hyperbranch Medical Technology
6.11. Integra Lifesciences Corp.,
6.12. Issuu Inc.,
6.13. Smith & Nephew plc,
6.14. Terumo Corp.,
6.15. Teleflex Inc.,
1. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
2. GLOBAL TOPICAL HEMOSTAT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
3. GLOBAL ADHESIVE AND TISSUE SEALANT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
4. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY MATERIAL, 2022-2030 ($ MILLION)
5. GLOBAL COLLAGEN-BASED TOPICAL HEMOSTATS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
6. GLOBAL GELATIN BASED TOPICAL HEMOSTATS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL ORC-BASED TOPICAL HEMOSTATS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
8. GLOBAL POLYSACCHARIDE BASED TOPICAL HEMOSTATS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
10. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR GENERAL SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
11. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR MINIMALLY INVASIVE SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
12. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR TRAUMA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
13. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
14. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
15. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
16. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
17. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
18. NORTH AMERICAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
19. NORTH AMERICAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
20. NORTH AMERICAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY MATERIAL, 2022-2030 ($ MILLION)
21. NORTH AMERICAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
22. NORTH AMERICAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
23. EUROPEAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
24. EUROPEAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
25. EUROPEAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY MATERIAL, 2022-2030 ($ MILLION)
26. EUROPEAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
27. EUROPEAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
28. ASIA-PACIFIC HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
29. ASIA-PACIFIC HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
30. ASIA-PACIFIC HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY MATERIAL, 2022-2030 ($ MILLION)
31. ASIA-PACIFIC HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
32. ASIA-PACIFIC HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
33. REST OF THE WORLD HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
34. REST OF THE WORLD HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY MATERIAL, 2022-2030 ($ MILLION)
35. REST OF THE WORLD HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
36. REST OF THE WORLD HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
1. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
2. GLOBAL TOPICAL HEMOSTAT MARKET SHARE BY REGION, 2022 VS 2030 (%)
3. GLOBAL ADHESIVE AND TISSUE SEALANT MARKET SHARE BY REGION, 2022 VS 2030 (%)
4. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE BY MATERIAL, 2022 VS 2030 (%)
5. GLOBAL COLLAGEN-BASED TOPICAL HEMOSTATS MARKET SHARE BY REGION, 2022 VS 2030 (%)
6. GLOBAL GELATIN BASED TOPICAL HEMOSTATS MARKET SHARE BY REGION, 2022 VS 2030 (%)
7. GLOBAL ORC-BASED TOPICAL HEMOSTATS MARKET SHARE BY REGION, 2022 VS 2030 (%)
8. GLOBAL POLYSACCHARIDE BASED TOPICAL HEMOSTATS MARKET SHARE BY REGION, 2022 VS 2030 (%)
9. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
10. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR GENERAL SURGERY MARKET SHARE BY REGION, 2022 VS 2030 (%)
11. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR MINIMALLY INVASIVE SURGERY MARKET SHARE BY REGION, 2022 VS 2030 (%)
12. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR TRAUMA MARKET SHARE BY REGION, 2022 VS 2030 (%)
13. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR OTHER APPLICATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
14. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 VS 2030 (%)
15. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
16. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS FOR AMBULATORY SURGICAL CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
17. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
18. US HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
19. CANADA HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
20. UK HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
21. FRANCE HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
22. GERMANY HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
23. ITALY HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
24. SPAIN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
25. REST OF EUROPE HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
26. INDIA HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
27. CHINA HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
28. JAPAN HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
29. SOUTH KOREA HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
30. REST OF ASIA-PACIFIC HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
31. REST OF THE WORLD HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SIZE, 2022-2030 ($ MILLION)
